Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.

× No keyword cloud information.

21 in total

1. THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS.

Authors: J D BYBEE; D E ROGERS
Journal: J Lab Clin Med Date: 1964-07

2. ON THE MODE OF ACTION OF THE TETRACYCLINE ANTIBIOTICS IN STAPHYLOCOCCUS AUREUS.

Authors: J H HASH; M WISHNICK; P A MILLER
Journal: J Biol Chem Date: 1964-06 Impact factor: 5.157

3. LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.

Authors: C A SCHINDLER; V T SCHUHARDT
Journal: Proc Natl Acad Sci U S A Date: 1964-03 Impact factor: 11.205

4. PURIFICATION AND PROPERTIES OF STAPHYLOLYTIC ENZYMES FROM CHALAROPSIS SP.

Authors: J H HASH
Journal: Arch Biochem Biophys Date: 1963-09 Impact factor: 4.013

5. An analysis of the effects of penicillin on an experimental infection produced by penicillin-resistant staphylococci.

Authors: D B LOURIA; D E ROGERS
Journal: J Lab Clin Med Date: 1960-02

6. Modified Gots test for penicillinase production.

Authors: T H HAIGHT; M FINLAND
Journal: Am J Clin Pathol Date: 1952-08 Impact factor: 2.493

7. The survival of staphylococci within human leukocytes.

Authors: D E ROGERS; R TOMPSETT
Journal: J Exp Med Date: 1952-02 Impact factor: 14.307

8. Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants.

Authors: M G KOENIG
Journal: Yale J Biol Med Date: 1962-06

9. An experimental analysis of the curative action of penicillin in acute bacterial infections. I. The relationship of bacterial growth rates to the antimicrobial effect of penicillin.

Authors: W B WOOD; M R SMITH
Journal: J Exp Med Date: 1956-04-01 Impact factor: 14.307

10. Factors relating to the virulence of Staphylococci. II. Observations on four mouse-pathogenic strains.

Authors: M G KOENIG; M A MELLY; D E ROGERS
Journal: J Exp Med Date: 1962-11-01 Impact factor: 14.307

20 in total

1. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.

Authors: M W Climo; K Ehlert; G L Archer
Journal: Antimicrob Agents Chemother Date: 2001-05 Impact factor: 5.191

2. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.

Authors: Caroline M Kusuma; John F Kokai-Kun
Journal: Antimicrob Agents Chemother Date: 2005-08 Impact factor: 5.191

3. Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin.

Authors: R L Patron; M W Climo; B P Goldstein; G L Archer
Journal: Antimicrob Agents Chemother Date: 1999-07 Impact factor: 5.191

4. Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.

Authors: K E Quickel; R Selden; J R Caldwell; N F Nora; W Schaffner
Journal: Appl Microbiol Date: 1971-09

5. Phagocytosis and intracellular killing of coagulase-negative staphylococci.

Authors: F Namavar; J de Graaff; D M MacLaren
Journal: Med Microbiol Immunol Date: 1979-03-13 Impact factor: 3.402

6. Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers.

Authors: J M Vann; R A Proctor
Journal: Infect Immun Date: 1987-09 Impact factor: 3.441

Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.